Chrysea is a synthetic biology company developing precision healthy-lifespan interventions supported by rigorous clinical research, aimed at optimising natural occurring anti-ageing mechanisms such as autophagy. Based on its synthetic biology platform, Chrysea develops naturally occurring small molecules and their production routes, which can play a potential role in addressing unmet needs associated to age-related diseases.